Journals / Anadolu Kardiyoloji Dergisi / 2012 / Cilt: 12 - Sayı: 3

When to take arms against a sea of troubles: CRT- still a challenging question (Author Reply)

Aksilik denizine karşı ne zaman kuvvet toplamalıyız: CRT - hala meydan okuyan bir sorundur

Pages
277–278
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

MİNARDİ, G., ZAMPİ, G., PUGLİESE, M. (2022). When to take arms against a sea of troubles: CRT- still a challenging question (Author Reply). Anadolu Kardiyoloji Dergisi, Cilt: 12 - Sayı: 3, 277–278. https://ajindex.com/articles/436359

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, van Gelder IC, Dickstein K, et al. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter-defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009; 11: 1143-51
  2. Bijnens B, Sitges M. Evaluating patients for CRT, what’s relevant: identifying responders or estimating the amount of potential response? Anadolu Kardiyol Derg 2012; 12: 00.00
  3. Authors/Task Force Members, Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 2010; 31: 2677-87
  4. Gervais R, Leclercq C, Shankar A, Jacobs S, Eiskjaer H, Johannessen A, et al. Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. Eur J Heart Fail 2009; 11: 699-705
  5. Linde C, Gold M, Abraham WT, Daubert JC; REVERSE Study Group. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure-the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Am Heart J 2006; 151: 288-94
  6. Pugliese M, Minardi G, Vitali A, Natale E, De Girolamo P, Zampi G, et al. Influence of myocardial viability on responsiveness to cardiac resynchronization in ischemic dilated cardiomyopathy: a prospective observational cohort study. Anadolu Kardiyol Derg 2012; 12: 132-41
  7. Ciampi Q, Pratali L, Citro R, Villari B, Picano E, Sicari R. Clinical and prognostic role of pressure-volume relationship in the identification of responders to cardiac resynchronization therapy. Am Heart J 2010; 160: 906-14
  8. Ypenburg C, Sieders A, Bleeker GB, Holman ER, van der Wall EE, Schalij MJ, et al. Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy. Am Heart J 2007; 154: 1160-5
  9. Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de Roos A, et al. Effect of posterolateral s